{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:09:29Z","timestamp":1790615369746,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ejogrb.2009.06.018","type":"journal-article","created":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T05:18:07Z","timestamp":1247894287000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin"],"prefix":"10.1016","volume":"147","author":[{"given":"Werner","family":"Rath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2009.06.018_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1471-0528.1988.tb06475.x","article-title":"The effects of routine oxytocic administration in the management of the third stage of labor: an overview of the evidence from controlled clinical trials","volume":"95","author":"Prendiville","year":"1988","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib2","first-page":"91","article-title":"Maternal mortality in the United States: report from the Maternal Mortality Collaborative","volume":"72","author":"Rochat","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0020-7292(96)02667-7","article-title":"The postpartum period: the key to maternal mortality","volume":"54","author":"Li","year":"1996","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib4","series-title":"Global estimates of maternal mortality for 1995: results of an in-depth review analysis and estimation strategy (statement)","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/1381612053381882","article-title":"Pharmacological and surgical therapy for primary postpartum haemorrhage","volume":"11","author":"Bouwmeester","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00001703-200404000-00008","article-title":"Current strategies for the prevention of postpartum haemorrhage in the third stage of labour","volume":"16","author":"Chong","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejogrb.2007.04.007","article-title":"Use of oxytocin to prevent haemorrhage at caesarean section\u2013a survey of practice in the United Kingdom","volume":"137","author":"Wedisinghe","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/01443610600955792","article-title":"Blood transfusion and caesarean section in a developing country","volume":"26","author":"Ozumba","year":"2006","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib9","first-page":"425","article-title":"Half-life of oxytocin in blood of pregnant and non-pregnant women","volume":"61","author":"Ryden","year":"1969","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1113\/jphysiol.1969.sp008937","article-title":"The clearance and antidiuretic potency of neurohypophysal hormones in man, and their plasma binding and stability","volume":"204","author":"Fabian","year":"1969","journal-title":"J Physiol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1677\/joe.0.0480223","article-title":"The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood","volume":"48","author":"Chard","year":"1970","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib12","doi-asserted-by":"crossref","unstructured":"McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev; 2004 [Issue I. Art. No: CD000201].","DOI":"10.1002\/14651858.CD000201.pub2"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib13","doi-asserted-by":"crossref","unstructured":"Liabsuetrakul T, Choobun T, Peeyanajarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev; 2007 [Issue 2. Art. No: CD005456].","DOI":"10.1002\/14651858.CD005456.pub2"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1471-0528.2002.01204.x","article-title":"A randomized controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour","volume":"109","author":"Choy","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/01443618109067375","article-title":"A reappraisal of the use of ergometrine","volume":"1","author":"Dumoulin","year":"1981","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1471-0528.1993.tb14319.x","article-title":"Adverse cardiovascular sequelae of ergometrine","volume":"100","author":"Carey","year":"1993","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib17","doi-asserted-by":"crossref","unstructured":"G\u00fclmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of Postpartum haemorrhage. Cochrane Database Syst Rev; 2004 [Issue I. Art. No: CD000494].","DOI":"10.1002\/14651858.CD000494.pub2"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib18","first-page":"1301","article-title":"Systematic review of randomized controlled trials of misoprostol to prevent postpartum haemorrhage","volume":"100","author":"Villar","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0029-7844(97)00275-5","article-title":"Severe hyperthermia following oral misoprostol in the immediate postpartum period","volume":"90","author":"Chong","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1701-2163(16)30659-4","article-title":"Comparison of carbetocin and oxytocin for the prevention of postpartum haemorrhage following vaginal delivery: a double-blind randomized trial","volume":"26","author":"Boucher","year":"2004","journal-title":"J Obstet Gynecol Can"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1471-0528.2006.01105.x","article-title":"A randomized trial of carbetocin versus syntometrine in the management of the third stage of labour","volume":"113","author":"Leung","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijgo.2007.02.005","article-title":"Carbetocin versus a combination of oxytocin and ergometrine in control of postpartum blood loss","volume":"97","author":"Ngan","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib23","doi-asserted-by":"crossref","unstructured":"Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum haemorrhage. Cochrane Database Syst Rev; 2007 [Issue 3. Art. No: CD005457].","DOI":"10.1002\/14651858.CD005457.pub2"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib24","first-page":"971","article-title":"Uterotonic activity and myometrial receptor affinity of I-deamino-I-carba-2-tyrosine (O-methyl)-oxytocin","volume":"19","author":"Atke","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib25","first-page":"566","article-title":"Contractile effect of oxytocin and I-deamino-l-carba-2-tyrosine (O-methyl)-oxytocin in myometrial tissue from non-pregnant and term pregnant women","volume":"122","author":"Norstr\u00f6m","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib26","first-page":"520","article-title":"Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in nonpregnant women","volume":"47","author":"Sweeney","year":"1990","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.1992.103","article-title":"Effect of carbetocin, a long-acting oxytocin analogue in the postpartum uterus","volume":"52","author":"Hunter","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0301-2115(97)00260-1","article-title":"Ascending dose tolerance study of intramuscular carbetocin administered after normal vaginal birth","volume":"77","author":"van Dongen","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib29","first-page":"202","article-title":"Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section","volume":"18","author":"Boucher","year":"1998","journal-title":"J Perinatol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(99)70271-1","article-title":"Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section","volume":"180","author":"Dansereau","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib31","first-page":"185","article-title":"The safety and efficiency of carbetocin to control uterine bleeding following caesarean section","volume":"1","author":"Barton","year":"1996","journal-title":"Prenat Neonatal Med"},{"issue":"6","key":"10.1016\/j.ejogrb.2009.06.018_bib32","doi-asserted-by":"crossref","first-page":"A254","DOI":"10.1016\/S1098-3015(10)63364-5","article-title":"Economic evaluation of carbetocine for the prevention of uterine atony in patients with risk factors in Mexico","volume":"9","author":"Del Angel-Garcia","year":"2006","journal-title":"Value Health"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib33","unstructured":"Ferring Pharmaceuticals: Global Pharmacovigilance. Periodic safety update report for carbetocin. 17 July 2006. On file at Ferring Pharmaceutical A\/S, Copenhagen. Denmark."},{"key":"10.1016\/j.ejogrb.2009.06.018_bib34","first-page":"456","article-title":"Transfer of carbetocin into human breast milk","volume":"82","author":"Silcox","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.06.018_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic sensitivity analysis using Monte Carlo Simulation. A practical approach","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med Decis Making"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211509004229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211509004229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:20:40Z","timestamp":1759555240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211509004229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0301211509004229"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2009.06.018","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2009.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}